Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils. (Q45121605)
Jump to navigation
Jump to search
scientific article published in November 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils. |
scientific article published in November 2004 |
Statements
Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils (English)
Takashi Kyoi
Kumiko Noda